Investor Presentaiton

Strong Operational metrics No. of Patient Visits (In Mn.) Revenue Per Patient (In Rs.) METROPOLIS The Pathology Specialist 2.5 Q3FY22 5.4 +15.7% No. of Tests (In Mn.) Q3FY22 +3.6% 2.9 924 957 Q3FY23 Q3FY22 +13.5% 6.2 Q3FY23 Q3FY23 Revenue Per Test (In Rs.) +5.6% 426 450 Q3FY22 Q3FY23 ✓ Company recorded strong growth in No. of patients & No. of tests. No. of patients for Q3FY23 increased by 15.7% and No. of tests for Q3FY23 increased by 13.5% on Y-o-Y basis ✓ Our revenue per patient has increased by 3.6% for Q3FY23 on Y-o-Y basis, on the back of higher specialised testing & stability in our pricing strategy Q3FY22 includes Hitech Diagnostics w.e.f 22nd Oct 2021; data excl. Covid & allied test 10

View entire presentation